---
figid: PMC3228218__onc9991108090001
figtitle: 'HCG/MET signaling pathway '
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3228218
filename: onc9991108090001.jpg
figlink: /pmc/articles/PMC3228218/figure/F1/
number: F1
caption: 'Schematic representation of HCG/MET signaling pathway []. Activation of
  MET results in the recruitment of scaffolding proteins such as Gab1 and Grb2, which
  activate Shp2, Ras, and ERK/MAPK. Abbreviations: ERK/MAPK, extracellular signal–regulated
  kinase/mitogen-activated protein kinase; Gab1, growth factor receptor–bound protein
  2 (Grb2)-associated binder 1; HGF/SF, hepatocyte growth factor/scatter factor; MET,
  mesenchymal-epithelial transition factor; Pak, p21-activated protein kinase; PI3K,
  phosphatidylinositol 3-kinase; PKB, protein kinase B; Shp2, SH2 domain–containing
  protein tyrosine phosphatase 2; SH2, Src-homology-2; Sos, son-of-sevenless; α and
  β, subunits of the receptor that are present after proteolytic cleavage. Adapted
  by permission from Macmillan Publishers Ltd. Birchmeier C, Birchmeier W, Gherardi
  E et al. Metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915–925.'
papertitle: Early Clinical Development of ARQ 197, a Selective, Non–ATP-Competitive
  Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Advanced Cancers.
reftext: Alex A. Adjei, et al. Oncologist. 2011 Jun;16(6):788-799.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9616389
figid_alias: PMC3228218__F1
figtype: Figure
redirect_from: /figures/PMC3228218__F1
ndex: c3366f60-dedb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3228218__onc9991108090001.html
  '@type': Dataset
  description: 'Schematic representation of HCG/MET signaling pathway []. Activation
    of MET results in the recruitment of scaffolding proteins such as Gab1 and Grb2,
    which activate Shp2, Ras, and ERK/MAPK. Abbreviations: ERK/MAPK, extracellular
    signal–regulated kinase/mitogen-activated protein kinase; Gab1, growth factor
    receptor–bound protein 2 (Grb2)-associated binder 1; HGF/SF, hepatocyte growth
    factor/scatter factor; MET, mesenchymal-epithelial transition factor; Pak, p21-activated
    protein kinase; PI3K, phosphatidylinositol 3-kinase; PKB, protein kinase B; Shp2,
    SH2 domain–containing protein tyrosine phosphatase 2; SH2, Src-homology-2; Sos,
    son-of-sevenless; α and β, subunits of the receptor that are present after proteolytic
    cleavage. Adapted by permission from Macmillan Publishers Ltd. Birchmeier C, Birchmeier
    W, Gherardi E et al. Metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915–925.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - se
  - drk
  - dos
  - Sos
  - Cdc42
  - Rac1
  - Rac2
  - ras
  - Ras64B
  - Ras85D
  - csw
  - Crk
  - .na.character
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Rala
  - r-l
  - rai
  - C3G
  - c(3)G
  - Akt
  - Pak
  - mbt
  - MKP-4
  - p38b
  - rl
  - Erk7
  - Rap1
  - AP-1gamma
  - Jra
  - kay
  - WASp
  - Rbf
  - DCTN6-p27
  - dap
  - CG9588
  - upd1
  - cass
  - Pen
  - alphaTub85E
  - Prosalpha2
  - nAChRalpha2
  - A3
  - nAChRalpha3
  - Prosalpha3
  - alphaTub84D
  - Dronc
  - Fak
  - scb
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - HGF
  - IL6
  - SOS1
  - GRB2
  - GAB1
  - PIGU
  - XYLT2
  - SOS2
  - CDC42
  - RAC1
  - RNASE1
  - KRAS
  - HRAS
  - NRAS
  - PTPN11
  - CRK
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RALA
  - RALB
  - GDF1
  - RNH1
  - PPP1R13L
  - SHC3
  - RAPGEF1
  - AKT1
  - PTK2B
  - AKT2
  - AKT3
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - ETS1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - WASL
  - RB1
  - CDK6
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - PLAU
  - PRAP1
  - BAD
  - GPR162
  - IGKV2-24
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - PTK2
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Met
  - Cancer
  - Noonan syndrome
---
